• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Inspire Veterinary Partners Inc. filed SEC Form 8-K: Other Events

    8/20/25 3:40:56 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $IVP alert in real time by email
    false 0001939365 0001939365 2025-08-20 2025-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 20, 2025

     

    INSPIRE VETERINARY PARTNERS, INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41792   85-4359258
    (State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
    of incorporation)       Identification No.)

     

    780 Lynnhaven Parkway, Suite 400
    Virginia Beach, VA
      23452
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (757) 734-5464

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common stock, par value $0.0001   IVP   Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 8.01 Other Events.

     

    As previously disclosed, on April 10, 2025, Inspire Veterinary Partners, (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of $1,562,005, as reported in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, the Company is no longer in compliance with the minimum stockholders’ equity requirement for continued inclusion on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”).

     

    The Company had 45 calendar days from the date of the Notice to submit its plan to regain compliance to Nasdaq, which was submitted on May 23, 2025.

     

    Also, as previously disclosed, on July 28, 2025, the Company entered into a Securities Purchase Agreement with certain accredited investors for of up to 7,590 shares of Series B convertible preferred stock (“Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s common stock (the “Private Placement”). The aggregate offering amount is up to $10 million, to be completed in one or more closings.

     

    On July 29, 2025, the Company completed the first closing of the Private Placement, issuing 6,340 shares of Series B Preferred Stock and 6,340,000 Warrants for aggregate proceeds of approximately $5 million. Proceeds were received in cash and through the transfer of certain securities in lieu of cash.

     

    As of the date of this Report on Form 8-K, the Company believes, as a result of the first closing of the Private Placement, it has regained compliance with the Stockholders’ Equity Requirement.

     

    Nasdaq will continue to monitor the Company’s ongoing compliance with the stockholders’ equity requirement and, if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 20, 2025 INSPIRE VETERINARY PARTNERS, INC.
       
      By: /s/ Kimball Carr
      Name:  Kimball Carr
      Title: President and Chief Executive Officer

     

     

    2

     

     

    Get the next $IVP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Watters Timothy

    4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

    8/14/25 4:26:35 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 4 filed by Director Murphy Anne

    4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

    8/11/25 3:54:07 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 4 filed by Director Lawrence Alexander

    4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

    8/8/25 2:48:17 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    $IVP
    SEC Filings

    View All

    SEC Form DEF 14C filed by Inspire Veterinary Partners Inc.

    DEF 14C - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

    8/21/25 8:07:27 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    Inspire Veterinary Partners Inc. filed SEC Form 8-K: Other Events

    8-K - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

    8/20/25 3:40:56 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SCHEDULE 13G/A filed by Inspire Veterinary Partners Inc.

    SCHEDULE 13G/A - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

    8/14/25 9:19:19 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    $IVP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results

    VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.Select Third Quarter 2024 Highlights Compared to Prior Year PeriodTotal revenue of approximately $4.0 million, a decrease of 1.7%Services revenue of $2.9 million, an increase of 1%Product revenue of $1.1 million, a decrease of 9%G&A decreased 16%Net loss decreased 56%Total revenue of approximately $13.3 million, an increase of 3%Services revenue of approximately $9.7 million, an increase of 6%Pr

    11/13/24 5:56:00 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

    NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is proud to announce its successful completion of several notable transactions throughout October 2024. The deals demonstrate Spartan's expertise and unwavering commitment to supporting clients' growth and capital needs across diverse sectors. In October, Spartan Capital Securities served as the placement agent for 1847 Holdings LLC's follow-on offering, raising $11,099,985. This capital infusion will enable 1847 Holdings LLC (NYSE:EFSH), a diversified holding company, to continue its growth strategy, enhance operational flexibility, and pursue acquisition opportunit

    11/1/24 2:36:24 PM ET
    $EFSH
    $IVP
    $TPET
    Professional Services
    Consumer Discretionary
    Farming/Seeds/Milling
    Consumer Staples

    Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

    New York, NY, Oct. 28, 2024 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Inspire Veterinary Partners, Inc.'s (NASDAQ:IVP) $2.5 million registered direct offering of Class A common stock. Inspire Veterinary Partners, a provider of veterinary healthcare services throughout the U.S., has entered into a securities purchase agreement with institutional investors to sell 10,000,000 shares of Class A common stock at a price of $0.25 per share. The offering is expected to generate gross proceeds of $2.5 million, before deducting placement agent fees and other related expenses. The company pl

    10/28/24 4:36:58 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    $IVP
    Financials

    Live finance-specific insights

    View All

    Inspire Veterinary Partners Announces Acquisition of Valley Veterinary Service Animal Hospital

    Latest acquisition brings the total number of Inspire locations to 14.Expansion into a new state, Pennsylvania.Pipeline of attractive potential acquisitions of animal hospitals remains active.VIRGINIA BEACH, VA / ACCESSWIRE / November 8, 2023 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has completed the acquisition of Valley Veterinary Service, Inc. animal hospital located in Pennsylvania, Inspire's first entry in that state.Valley Veterinary Service's 2022 gross revenues were in excess of $1.7 million. As part of the transaction, Inspire acquired certain real est

    11/8/23 2:00:00 AM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    $IVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Inspire Veterinary Partners Inc.

    SC 13G/A - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

    10/11/24 4:05:57 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form SC 13G filed by Inspire Veterinary Partners Inc.

    SC 13G - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

    7/19/24 9:30:47 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    $IVP
    Leadership Updates

    Live Leadership Updates

    View All

    Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

    VIRGINIA BEACH, VA / ACCESSWIRE / August 27, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a non-binding letter of intent (the "LOI") with Vetsie.ai, an Artificial Intelligence ("AI") software platform designed to empower veterinary professionals with quick, accurate access to critical information on patient conditions, treatments, and medications, to engage in diligence and initial negotiations regarding the terms of a potential transaction whereby Inspire may Acquire Vetsie.ai in an all- stock transaction. This potential equity-only acquisiti

    8/27/24 8:30:00 AM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples

    Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

    VIRGINIA BEACH, VA / ACCESSWIRE / August 16, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that its board of directors has nominated Phillip Balatsos to stand for election as an independent director at its annual meeting of stockholders on October 9, 2024.Mr. Balatsos has served as the Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading with XP Investments US Inc. since August 2022. Mr. Balatsos provides coverage and execution of currency trading in emerging markets as well as commodity and fixed income products and derivatives for global macro hedg

    8/16/24 8:30:00 AM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples